Abstract
Consuelo Ahumada's article, Impact TRIPS and Free Trade Agreements have on Access to Medicines: The Cases of Canada and Colombia, discusses the consequences of American international trade strategies with regard to the pharmaceutical industry and national healthcare systems. Her article shows how successive rounds of international trade negotiations and bilateral free trade agreements have served to strengthen the intellectual property rights of multinational pharmaceutical companies. As Ahumada amply demonstrates, one of the outcomes of enhanced intellectual property regimes is that they have served to restrict access to medicines and have negatively affected the delivery of health care in Canada and Colombia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
